BioCentury
ARTICLE | Management Tracks

PureTech’s Zohar takes CEO role at new portfolio company targeting CNS

Plus: AskBio hires former Prevail CSO, and updates from Illumina, Xencor, Adcentrx, enGene and more

April 10, 2024 12:29 AM UTC

After nearly two decades as the founding CEO of PureTech Health plc (LSE:PRTC; NASDAQ:PRTC), Daphne Zohar is making the leap to be CEO of newly launched portfolio company Seaport Therapeutics Inc. She will step down from PureTech’s board, although she will remain a board observer and adviser.

PureTech is promoting its president, Bharatt Chowrira, to CEO, and has named co-founder and Chief Innovation Officer Eric Elenko as its new president...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article